Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $72.77 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $72.77 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $72.77 | 1 | GlaxoSmithKline, LLC. ($72.77) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $72.77 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,129 | 1,451 | $398,128 | $120,736 |
| 2022 | 30 | 2,124 | 2,629 | $517,157 | $174,995 |
| 2021 | 32 | 3,694 | 4,202 | $601,705 | $207,245 |
| 2020 | 18 | 1,114 | 1,579 | $356,217 | $92,198 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 429 | $161,685 | $38,162 | 23.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 66 | 66 | $52,470 | $18,540 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 116 | 116 | $42,688 | $15,659 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 177 | $46,773 | $10,782 | 23.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 82 | 112 | $17,024 | $10,483 | 61.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 71 | $37,176 | $9,319 | 25.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 71 | 73 | $15,537 | $5,495 | 35.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 63 | 79 | $8,295 | $5,253 | 63.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 85 | $2,550 | $2,558 | 100.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 65 | 65 | $5,265 | $2,088 | 39.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 74 | 85 | $3,400 | $809.20 | 23.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 18 | 18 | $1,170 | $752.80 | 64.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 30 | $2,550 | $345.68 | 13.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 12 | $764.00 | $261.18 | 34.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $561.00 | $178.20 | 31.8% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 21 | 22 | $220.00 | $51.04 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 480 | $162,720 | $44,934 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 255 | 436 | $99,844 | $27,542 | 27.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 85 | 85 | $67,575 | $23,634 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 85 | 85 | $31,280 | $11,617 | 37.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 94 | 121 | $18,392 | $11,414 | 62.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 131 | 133 | $24,339 | $9,332 | 38.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 105 | 142 | $14,910 | $9,114 | 61.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 48 | 48 | $26,016 | $8,398 | 32.3% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 143 | 144 | $14,256 | $6,018 | 42.2% |
About Dr. Joanne Spalding, M.D
Dr. Joanne Spalding, M.D is a Family Medicine healthcare provider based in Chowchilla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770693137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joanne Spalding, M.D has received a total of $72.77 in payments from pharmaceutical and medical device companies, with $72.77 received in 2023. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($72.77).
As a Medicare-enrolled provider, Spalding has provided services to 8,061 Medicare beneficiaries, totaling 9,861 services with total Medicare billing of $595,174. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Chowchilla, CA
- Active Since 08/30/2006
- Last Updated 10/11/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1770693137
Products in Payments
- AREXVY (Drug) $72.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.